Inventor · New York, NY, US

Mark Sleeman

25Patents
11h-index
20Co-inventors
75Inventor score

Filing activity: Dec 3, 1999 → Apr 5, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US8062640B2 High affinity human antibodies to PCSK9 Emerging Cross-Sectional Technologies 126 Active
US8357371B2 Methods for treating hypercholesterolemia using antibodies to PCSK9 Chemistry; Metallurgy 75 Active
US8501184B2 High affinity human antibodies to PCSK9 Emerging Cross-Sectional Technologies 69 Active
US7052691B2 Methods of treating diabetes by blocking VEGF-mediated activity Chemistry; Metallurgy 28 Expired
US8545847B2 Human antibodies to the human glucagon receptor and methods of use thereof Chemistry; Metallurgy 25 Active
US9018356B2 Anti-ANGPTL3 antibodies and uses thereof Chemistry; Metallurgy 21 Active
US7378095B2 Methods of treating type I diabetes by blocking VEGF-mediated activity Chemistry; Metallurgy 20 Expired
US9550837B2 Therapeutic uses of anti-PCSK9 antibodies Emerging Cross-Sectional Technologies 19 Active
US9127068B2 Nucleic acids encoding human glucagon receptor antibodies Chemistry; Metallurgy 18 Active
US10023654B2 Anti-PCSK9 antibodies Emerging Cross-Sectional Technologies 11 Active
US9724411B2 Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9 Chemistry; Metallurgy 11 Active
US9587029B2 Human antibodies to the glucagon receptor and methods of use thereof Chemistry; Metallurgy 11 Active
US9120851B2 Human antibodies to human angiopoietin-like protein 4 Chemistry; Metallurgy 9 Active
US8354103B2 Human antibodies to human angiopoietin-like protein 4 Chemistry; Metallurgy 4 Active
US10233250B2 Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels Chemistry; Metallurgy 4 Active
US10941210B2 Anti-PCSK9 antibodies Emerging Cross-Sectional Technologies 4 Active
US9951127B2 Anti-ANGPTL3 antibodies and uses thereof Chemistry; Metallurgy 2 Active
US12250931B2 Genetically modified mouse with a humanized PNPLA3 gene and methods of use Chemistry; Metallurgy 0 Active
US10358487B2 Anti-ANGPTL3 antibodies and uses thereof Chemistry; Metallurgy 0 Active
US11780915B2 Binding proteins to the human thrombin receptor, PAR4 Chemistry; Metallurgy 0 Active
US11498970B2 Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels Chemistry; Metallurgy 0 Active
US10640566B2 Nucleic acid molecules encoding antibodies to the human glucagon receptor Chemistry; Metallurgy 0 Active
US6680291B1 Modified ciliary neurotrophic factor, method of making and methods of use thereof Human Necessities 0 Expired
US12269897B2 Anti-PCSK9 antibodies Emerging Cross-Sectional Technologies 0 Active
US12269889B2 Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.